MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
30.42
+1.75 (6.10%)
At close: Dec 19, 2025, 4:00 PM EST
31.00
+0.58 (1.91%)
After-hours: Dec 19, 2025, 7:11 PM EST

MBX Biosciences Stock Forecast

Stock Price Forecast

The 8 analysts that cover MBX Biosciences stock have a consensus rating of "Strong Buy" and an average price target of $50.63, which forecasts a 66.44% increase in the stock price over the next year. The lowest target is $18 and the highest is $80.

Price Target: $50.63 (+66.44%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$18$50.63$50$80
Change-40.83%+66.44%+64.37%+162.98%

Analyst Ratings

The average analyst rating for MBX Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingJul '25Aug '25Sep '25Oct '25Nov '25Dec '25
Strong Buy344345
Buy344333
Hold000000
Sell000000
Strong Sell000001
Total688679

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Stifel
Stifel
Strong Buy
Maintains
$45$50
Strong BuyMaintains$45$50+64.37%Dec 19, 2025
Goldman Sachs
Goldman Sachs
Strong Sell
Initiates
$18
Strong SellInitiates$18-40.83%Dec 4, 2025
Guggenheim
Guggenheim
Strong Buy
Maintains
$84$77
Strong BuyMaintains$84$77+153.12%Nov 10, 2025
TD Cowen
TD Cowen
Strong Buy
Initiates
n/a
Strong BuyInitiatesn/an/aNov 4, 2025
Truist Securities
Truist Securities
Strong Buy
Initiates
$50
Strong BuyInitiates$50+64.37%Oct 15, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.64
from -5.82
EPS Next Year
-3.08
from -2.64
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026FY 2027FY 2028
Period EndingDec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027Dec 31, 2028
Revenue
------37.37M
Revenue Growth
-------
EPS
-39.18-31.96-5.82-2.64-3.08-3.85-3.43
EPS Growth
-------
Forward PE
-------
No. Analysts
---1010106
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue202520262027202820292030
Highn/an/a
Avgn/an/a
Lown/an/a

Revenue Growth

Revenue Growth202520262027202820292030
High--
Avg--
Low--

EPS Forecast

EPS202520262027202820292030
High-2.31-2.21
Avg-2.64-3.08
Low-2.76-4.49

EPS Growth

EPS Growth202520262027202820292030
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.